Cargando…
Coronavirus Disease 2019: Coronaviruses and Blood Safety
With the outbreak of unknown pneumonia in Wuhan, China, in December 2019, a new coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), aroused the attention of the entire world. The current outbreak of infections with SARS-CoV-2 is termed Coronavirus Disease 2019 (COVID-19). The...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7135848/ https://www.ncbi.nlm.nih.gov/pubmed/32107119 http://dx.doi.org/10.1016/j.tmrv.2020.02.003 |
_version_ | 1783518148792680448 |
---|---|
author | Chang, Le Yan, Ying Wang, Lunan |
author_facet | Chang, Le Yan, Ying Wang, Lunan |
author_sort | Chang, Le |
collection | PubMed |
description | With the outbreak of unknown pneumonia in Wuhan, China, in December 2019, a new coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), aroused the attention of the entire world. The current outbreak of infections with SARS-CoV-2 is termed Coronavirus Disease 2019 (COVID-19). The World Health Organization declared COVID-19 in China as a Public Health Emergency of International Concern. Two other coronavirus infections—SARS in 2002-2003 and Middle East Respiratory Syndrome (MERS) in 2012—both caused severe respiratory syndrome in humans. All 3 of these emerging infectious diseases leading to a global spread are caused by β-coronaviruses. Although coronaviruses usually infect the upper or lower respiratory tract, viral shedding in plasma or serum is common. Therefore, there is still a theoretical risk of transmission of coronaviruses through the transfusion of labile blood products. Because more and more asymptomatic infections are being found among COVID-19 cases, considerations of blood safety and coronaviruses have arisen especially in endemic areas. In this review, we detail current evidence and understanding of the transmission of SARS-CoV, MERS–CoV, and SARS-CoV-2 through blood products as of February 10, 2020, and also discuss pathogen inactivation methods on coronaviruses. |
format | Online Article Text |
id | pubmed-7135848 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71358482020-04-08 Coronavirus Disease 2019: Coronaviruses and Blood Safety Chang, Le Yan, Ying Wang, Lunan Transfus Med Rev Article With the outbreak of unknown pneumonia in Wuhan, China, in December 2019, a new coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), aroused the attention of the entire world. The current outbreak of infections with SARS-CoV-2 is termed Coronavirus Disease 2019 (COVID-19). The World Health Organization declared COVID-19 in China as a Public Health Emergency of International Concern. Two other coronavirus infections—SARS in 2002-2003 and Middle East Respiratory Syndrome (MERS) in 2012—both caused severe respiratory syndrome in humans. All 3 of these emerging infectious diseases leading to a global spread are caused by β-coronaviruses. Although coronaviruses usually infect the upper or lower respiratory tract, viral shedding in plasma or serum is common. Therefore, there is still a theoretical risk of transmission of coronaviruses through the transfusion of labile blood products. Because more and more asymptomatic infections are being found among COVID-19 cases, considerations of blood safety and coronaviruses have arisen especially in endemic areas. In this review, we detail current evidence and understanding of the transmission of SARS-CoV, MERS–CoV, and SARS-CoV-2 through blood products as of February 10, 2020, and also discuss pathogen inactivation methods on coronaviruses. Elsevier Inc. 2020-04 2020-02-21 /pmc/articles/PMC7135848/ /pubmed/32107119 http://dx.doi.org/10.1016/j.tmrv.2020.02.003 Text en © 2020 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Chang, Le Yan, Ying Wang, Lunan Coronavirus Disease 2019: Coronaviruses and Blood Safety |
title | Coronavirus Disease 2019: Coronaviruses and Blood Safety |
title_full | Coronavirus Disease 2019: Coronaviruses and Blood Safety |
title_fullStr | Coronavirus Disease 2019: Coronaviruses and Blood Safety |
title_full_unstemmed | Coronavirus Disease 2019: Coronaviruses and Blood Safety |
title_short | Coronavirus Disease 2019: Coronaviruses and Blood Safety |
title_sort | coronavirus disease 2019: coronaviruses and blood safety |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7135848/ https://www.ncbi.nlm.nih.gov/pubmed/32107119 http://dx.doi.org/10.1016/j.tmrv.2020.02.003 |
work_keys_str_mv | AT changle coronavirusdisease2019coronavirusesandbloodsafety AT yanying coronavirusdisease2019coronavirusesandbloodsafety AT wanglunan coronavirusdisease2019coronavirusesandbloodsafety |